Tag
Sun Pharma has agreed to acquire Organon & Co. for $11.75 billion in an all-cash deal, one of India's largest pharma acquisitions. The merger pushes Sun Pharma into the global top 25 by revenue and establishes it as a top-10 biosimilar player. The deal is expected to close in early 2027, pending regulatory and
Sun Pharma is set to acquire US drugmaker Organon for $12.5 billion, paying $4.5 billion in equity and assuming $8.5 billion in debt. The deal, Sun's largest ever, beats out a rival EQT-Gruenthal consortium bid. An official announcement is expected Sunday night or by Monday.
India's DCGI has reduced drug approval timelines by over 50%, with marketing authorizations now granted in under 150 days and clinical trial approvals in 120, 135 days. The regulator has also removed mandatory prior approval at the pre-clinical stage, lowering barriers for early drug development. Both changes are in eff
Tag
Sun Pharma has agreed to acquire Organon & Co. for $11.75 billion in an all-cash deal, one of India's largest pharma acquisitions. The merger pushes Sun Pharma into the global top 25 by revenue and establishes it as a top-10 biosimilar player. The deal is expected to close in early 2027, pending regulatory and
2mo ago · 1 min · Business
Sun Pharma is set to acquire US drugmaker Organon for $12.5 billion, paying $4.5 billion in equity and assuming $8.5 billion in debt. The deal, Sun's largest ever, beats out a rival EQT-Gruenthal consortium bid. An official announcement is expected Sunday night or by Monday.
2mo ago · 1 min · Business
India's DCGI has reduced drug approval timelines by over 50%, with marketing authorizations now granted in under 150 days and clinical trial approvals in 120, 135 days. The regulator has also removed mandatory prior approval at the pre-clinical stage, lowering barriers for early drug development. Both changes are in eff
2mo ago · 1 min · Policy & Government
— End of feed —